Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy
Radiotherapy (RT) has been shown to interfere with inflammatory signals and to enhance tumor immunogenicity via, e.g., immunogenic cell death, thereby potentially augmenting the therapeutic efficacy of immunotherapy. Conventional RT consists predominantly of high energy photon beams. Hypofractionate...
Main Authors: | Damiënne Marcus, Relinde I. Y. Lieverse, Carmen Klein, Amir Abdollahi, Philippe Lambin, Ludwig J. Dubois, Ala Yaromina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/6/1468 |
Similar Items
-
Enhancing the efficacy of immunotherapy using radiotherapy
by: Synat Keam, et al.
Published: (2020-01-01) -
Prospect of radiotherapy technology development in the era of immunotherapy
by: Jian-Yue Jin
Published: (2022-06-01) -
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy
by: Veronica Olivo Pimentel, et al.
Published: (2021-03-01) -
Human fibronectin extra domain B as a biomarker for targeted therapy in cancer
by: Relinde I. Y. Lieverse, et al.
Published: (2020-07-01) -
A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose
by: ZhengShan Hong, et al.
Published: (2023-03-01)